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Treatment compliance in  children with Crohn’s disease is associated with higher levels of 
symptom remission. We hypothesized that the management, comorbidities, and complications for 
children with Crohn’s disease would differ based on a diagnosis of noncompliance.  
 
Methods: 
Using  the Kids’ Inpatient Database for 2006-2012, we identified young patients (<21 years) with 
a diagnosis of Crohn’s disease. Diagnoses and procedures were analyzed according to  a recorded 
diagnosis of noncompliance. Multivariable logistic regression analysis was performed to examine 
the association between noncompliance and the outcomes of interest.  
 
Results: 
There were 28,337 pediatric Crohn’s disease hospitalizations identified with 1,028 (3.6%) 
hospitalizations having a diagnosis of both Crohn’s disease and noncompliance. The mean age of 
the study population was 15.9 years and 48.9% were girls. Black patients ( multivariable adjusted 
odds ratio, aOR,2.27; 95% CI:1.84-2.79) and those in the lowest income quartile (aOR 1.57; 95% 
CI:1.20-2.05) had an increased likelihood of a noncompliance diagnosis than respective 
comparison groups. Noncompliant patients had an increased likelihood of concurrent depression, 
nutritional deficiency, and anemia. Patients with a diagnosis of noncompliance had lower rates of 
intestinal obstruction (4.0% vs 6.3%), intraabdominal abscesses (2.0% vs 4.2%,), and underwent 
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fewer major surgical procedures (aOR 0.40; 95% CI:0.31-0.53) and large bowel resections (aOR 
0.44; 95% CI:0.31-0.64) than patients without this diagnosis. 
 
Conclusions: 
We found significant differences in socioeconomic status and race among hospitalized children 
with Crohn’s disease with, as compared to those without, a diagnosis of noncompliance. Children 
with noncompliance have different comorbidities, disease-related complications, and are managed 
differently. Possible explanations for observed treatment differences include a reluctance to offer 
surgery to those with a diagnosis of noncompliance, a refusal of intervention by noncompliant 
patients, or implicit bias. Further investigation is warranted to better define noncompliance in this 
population and to determine the implications of this diagnosis. 
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Chapter I: Introduction 
Pediatric Crohn’s Disease 
Crohn’s disease (CD), also known as regional enteritis, is an inflammatory disease which can 
affect any part of the gastrointestinal tract from the mouth to anus. It has a relapsing nature and 
frequently involves the ileum, ileum and cecum, or ileum and entire colon. In Western countries, 
between 20-30% of patients with CD are diagnosed before age 20 with a peak incidence of 
inflammatory bowel disease (IBD) occurring between the ages of 15 and 30 years [1-4]. There is 
some evidence that suggests that there has been an increase in the incidence of IBD worldwide 
over the past several decades [5-9]. 
Pediatric patients with CD face a more extensive and severe disease course than adults[10], 
coupled with unique long-term risks. With disease-related malabsorption, maldigestion, and 
reduced caloric intake coinciding with a developmentally critical time, young patients with CD are 
at high risk of osteopenia, growth failure, failure to thrive, and delayed puberty[11-13].  
This clinical syndrome is associated with psychosocial complications which compound the 
physical manifestations. Approximately 63% of adolescents with CD meet criteria for a psychiatric 
disorder compared with 18% of the general adolescent population[14] with adjustment disorder, 
major depressive disorder, and anxiety disorders predominating at 29%, 24%, and 10% 
respectively[15]. CD is associated with lower quality of life in adolescents which has been directly 
associated with increased disease activity[16]. 
 
Treatment Noncompliance In Pediatric Crohn’s Disease 
Remission for patients with CD is commonly achieved and maintained through the stepwise 
escalation of anti-inflammatory and immunosuppressant medications (Figure 1). Medication 
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adherence is critical to reducing disease activity but lacks a universal definition. Adherence in this 
context can be defined as the extent to which patients take medications they are prescribed whereas 
“compliance” suggests that the patient is passively following the instructions and that the treatment 
plan is not necessarily equal commitment from both parties [17]. Additional the term persistence 
is used in some situations to refer to the number of days taking the prescribed medication or 
following the planned treatment regimen [18]. Several studies of young patients with inflammatory 
bowel disease (IBD) have demonstrated volitional nonadherence or noncompliance in 35% of 
adolescents [19]. Unfortunately, most studies cannot differentiate nonadherence from 
noncompliance from nonpersistence. The net outcome for noncompliance, nonadherence or 
nonpersistence, however, is the same – failure to follow a prescribed  treatment regimen. 
One study in children and adolescents with newly diagnosed IBD defined adherence as 
taking at least 80% of prescribed medications [20]. Analysis of prescription refill rates in pediatric 
CD has shown that 60% of patients do not fill at least 80% of required medications[21]. Among 
adherent pediatric CD patients, 80% achieve disease remission compared with 34% of non-
adherent patients[21]. Among noncompliant patients with pediatric CD and ulcerative colitis (UC), 
25% experience therapy escalation and 13% require hospitalization for IBD sequelae, compared 
to 3% and 3% of compliant patients, respectively[21]. Additionally, a study of predominately adult 
patients found that patients who delayed refilling their anti-tumor necrosis factor (TNF) 
medications by more than two days on average every two weeks significantly increased their risk 
of experiencing a CD flare[22]. The association between CD treatment noncompliance and 
medical comorbidities, complications, and surgical interventions in the pediatric CD population is 
poorly understood.  
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Overview of the Kids’ Inpatient Database (KID): 
The KID is the largest publicly available administrative all-payer national sampling of pediatric (≤ 
20 years of age) inpatient discharges and is managed as part of the Healthcare Cost and Utilization 
Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ)[23]. Each iteration 
of the KID involves between >3,700 hospitals, and >6.7 million national discharges among 
children and adolescents aged < 21 years. The number of participating states were 38, 44, and 44 
for  the study years of 2006, 2009, and 2012, respectively. The KID is produced triennially and 
includes data from non-federal hospitals, short-term stay hospitals, academic medical centers, and 
specialty hospitals. Hospitals not included in the dataset are federal hospitals, rehabilitation 
hospitals, psychiatric hospitals, or substance treatment centers. The KID represents a sample of 
approximately 80% of all pediatric discharges during the years under study. 
 The KID contains over 100 sociodemographic and clinical variables and utilizes an 
International Classification of Diseases, Ninth Revision (ICD-9) classification system of both 
diagnoses and procedures. It also includes variables regarding payer, geographic region, hospital 
charges, length of stay, and hospital characteristics including size and teaching status (Figure 2). 
Due to the nature of the KID as a discharge-level database, patients hospitalized multiple times 
have multiple records in the KID. 
 
Specific Aims: 
The primary aim of this observational study was to examine, among children and young adults 
with CD, the characteristics of patients who received a diagnosis of treatment noncompliance as 
compared with those who did not. The secondary aims of the study were to evaluate the effect of 
noncompliance on associated comorbidities, complications, and treatment interventions. We 
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utilized the Kids’ Inpatient Database for the years 2006, 2009, and 2012 to examine these outcomes 




Chapter II: Methods 
Data Source 
Using the Kids’ Inpatient Database (KID), a cross-sectional analysis was performed after 
combining the three study years of 2006, 2009, and 2012 into a single dataset.  
 
Case Selection 
Patients were identified using ICD-9 diagnosis codes related to CD. We utilized the following 
ICD-9 codes – 555, 555.0, 555.1, 555.2, and 555.9 in either the primary or secondary diagnostic 
positions. This study population was further stratified according to the  ICD-9 code of V15.81 – a 
personal history of noncompliance with medical treatment, presenting hazards to health. To 
identify procedures and comorbidities, we used the ICD-9 and single-level Clinical Classifications 
Software (CCS) (Appendix I and II). The CCS is a diagnosis and procedure categorization scheme 
developed by AHRQ as part of HCUP[24].  
 Children and young adults with CD  were excluded from the study if there was a concern 
for indeterminate colitis (presence of ICD-9 codes for both UC and CD), if the hospitalization 
involved trauma (as defined by ICD-9 E-codes), and if there were missing data from critical 
variables including age, gender, race, primary payer, mortality, total hospital charges, and median 
income quartile by zip code. If coding abnormalities in the ICD-9 codes were identified using 
STATA 15.0 statistical software (2017; College Station, TX), those cases were also excluded. 
Overall, 24.4% of cases were excluded, and the main reasons for exclusion were due to missing 
data on race (63.9%) and trauma (14.7%). 
Trauma 2601 E Codes: Cut/pierce 
2602 E Codes: Drowning/submersion 
2603 E Codes: Fall 
2604 E Codes: Fire/burn 
2605 E Codes: Firearm 
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2606 E Codes: Machinery 
2607 E Codes: Motor vehicle traffic (MVT) 
2608 E Codes: Pedal cyclist; not MVT 
2609 E Codes: Pedestrian; not MVT 
2610 E Codes: Transport; not MVT 
2611 E Codes: Natural/environment 
2613 E Codes: Poisoning 
2614 E Codes: Struck by; against 
2615 E Codes: Suffocation 
 
Independent and Dependent Variables 
Patient characteristics included age, gender, race, health insurance type, income quartile by median 
income by zip code, and whether the admission was elective or otherwise. Hospital course 
variables included the length of stay (LOS) and total hospital charges (USD$), which were 
standardized to 2018 U.S. Dollar values[25]. Age was evaluated both continuously and 
categorically with four age groups that were defined by school-age: elementary school (<10 years, 
ES), middle school (11-13 years, MS), high school (14-18 years, HS) and post-high school (19-20 
years). Patient location was defined as urban (central and fringe counties of ≥1 million population), 
suburban (counties in metro areas of 250k- <1 million and counties 50k - <250k), and rural 
(micropolitan or non-core counties). Payer information was consolidated into private, government 
(Medicaid, Medicare), and other. Four distinct hospital regions were defined by the U.S. Census 
Bureau definitions[26]. Major surgical procedure is an HCUP-defined variable in the KID 
indicating the presence of a major therapeutic or diagnostic procedure that occurred during 
hospitalization. The comorbidities and interventions assessed were defined using ICD-9 codes. 
The comorbidities assessed included anxiety, anemia, depression, nutritional deficiency, intestinal 
obstruction, perianal disease, peritonitis, peritoneal or intestinal abscess, and presence of an 
ostomy. The interventions examined included having either an upper gastrointestinal endoscopy 
(EGD) colonoscopy, vascular catheterization, or a small or large bowel resection  performed,  
receipt of a blood transfusion, and use of supplemental parenteral or enteral nutrition. 
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Diagnosis ICD-9 Code 
Anemia 285.9 – Anemia 
285.29 – Anemia of chronic disease 
280.0 – Iron deficiency anemia secondary to chronic blood loss 
280.9 – Iron deficiency anemia 
Anxiety 300.0 – Anxiety states 
300.00 – Anxiety state, unspecified  
300.01 – Panic disorder without agoraphobia  
300.02 – Generalized anxiety disorder  
300.09 – Other anxiety states 
Depression 311 – Depressive disorder, not elsewhere classified 
Intestinal Obstruction 560.8 – Other specified intestinal obstruction 
560.81 – Intestinal or peritoneal adhesions with obstruction 
(postoperative) (postinfection) 
560.89 – Other specified intestinal obstruction  
560.9 – Unspecified intestinal obstruction  
Perianal Disease 565.0 – Anal fissure 
565.1 – Anal fistula 
566 – Abscess of anal and rectal regions 
Peritonitis 567.0 – Peritonitis in infectious diseases classified elsewhere  
567.2 – Other suppurative peritonitis 
567.21 – Peritonitis (acute) generalized 
567.29 – Other suppurative peritonitis 
567.3 – Retroperitoneal infections 
567.31 – Psoas muscle abscess 
567.38 – Other retroperitoneal abscess 
567.39 – Other retroperitoneal infections 
567.8 – Other specified peritonitis 
Peritoneal or Intestinal Abscess 567.22 – Peritoneal Abscess 
569.5 – Abscess of intestine 
Ileostomy PRCCS 73 – Ileostomy and other enterostomy 
V44.2 – status post ileostomy 
V55.2 – Attention to ileostomy 
Presence of Ileostomy V44.2 – status post ileostomy 
V55.2 – Attention to ileostomy 
Noncompliance V15.81 – Personal history of noncompliance with medical treatment, 
present hazards to health 
 
Procedures PR-CCS Code (ICD-9) 
Upper Gastrointestinal Endoscopy 70 – Upper gastrointestinal endoscopy, biopsy 
Colonoscopy 76 – Colonoscopy and Biopsy 
Vascular Catheterization 54 – Other vascular catheterization; not heart 
Blood Transfusion 222 – Blood transfusion 
Parenteral or Enteral Nutrition 223 – Enteral and parenteral nutrition 
Any Small Bowel Resection 75 – Small bowel resection 
Any Large Bowel Resection 78 – Colorectal Resection 
Diagnosis CCS Code (ICD-9) 




We examined diffenences in the distribution of categorical variables, using chi-square tests, and 
Student’s t-test for continuous variables, between children and young adults with CD with a 
diagnosis of noncompliance in comparison with  those who were defined as compliant. All 
statistical tests were two-sided with statistical significance considered as a p-value <0.05. The data 
were weighted, using HCUP-provided weights, to be representative of all U.S. inpatient discharges 
using the STATA svy function. A multivariable logistic regression analysis was performed to 
assess patient characteristics (gender, race, age group, patient location, income quartile, and health 
insurance payer) associated with a diagnosis of noncompliance. To assess our secondary aims, 
separate independent multivariable logistic regression analyses were performed to examine the 
association between a diagnosis of noncompliance with comorbidities and interventions; this 
model adjusted for the following potentailly confounding variables: gender, race, age group, 
patient location, income quartile, and health insurance payer. These factors were selected based on 
differences between the comparison compliant and noncompliant patient populations . All 
statistical analyses were performed using STATA 15.0 statistical software. 
 
Ethical Considerations: 
The Institutional Review Board at the University of Massachusetts Medical School deemed 
this study exempt from IRB review due to the de-identified nature of the data. In compliance with 
the KID data use agreement, this study does not report information where the number of 
observations is less than or equal to 10. 
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Chapter III: Results 
There were a total of 28,337 pediatric hospitalizations involving CD during the three years under 
study (2006, 2009, and 2012). Among these, 1,028 (3.6%) hospitalizations had a diagnosis of 
noncompliance. The overall population of patients with a diagnosis of CD was predominately 
male, non-Hispanic white, resided in the South, in the highest income quartile, had private health 
insurance, lived in urban environments, and had a mean age of 15.9 years  (Table 1). The frequency  
of a diagnosis of noncompliance in hospitalized children and young adults with CD slightly 
increased from 3.3% in 2006 to 3.9% in 2009. 
 
Patient Characteristics Associated with A Diagnosis Of Noncompliance 
In examining differences in various characteristics between children with, as compared to those 
without, a diagnosis of noncompliance (Table 1), boys were significantly more likely to carry a 
diagnosis of noncompliance, and noncompliant children were less likely to be non-Hispanic white, 
Asian, or Pacific Islander than girls and whites, respectively (Table 1). On the other hand, black 
children and young adults with CD were more likely to have a diagnosis of noncompliance 
thannon-Hispanic white children. In addition, children in  ES and MS were significantly less likely, 
whereas post-high school students were significantly more likely, to have a diagnosis of 
noncompliance. Patients with a diagnosis of noncompliance were significantly less likely to have 
an elective hospitalization or private health insurance. The highest proportion of those with a 




Comorbidities, Complications, And Interventions Associated With A Diagnosis of 
Noncompliance  
Compared to those without a diagnosis of noncompliance, there were higher rates of anemia, 
anxiety, depression, and nutritional deficiency in those diagnosed with noncompliance (Table 3). 
The rates of intestinal obstruction and peritoneal or intestinal abscess were significantly higher in 
those without the noncompliance diagnosis. The rates of perianal disease and peritonitis were 
similar. 
 The rates of small bowel resection, non-cardiac vascular catheterization, and the use of 
enteral or parenteral nutrition were similar between the two comparison  groups. Patients with the 
diagnosis of noncompliance underwent significantly fewer upper gastrointestinal endoscopies, 
colonoscopies, large bowel resections, and major surgical procedures than patients without a 
diagnosis of noncompliance. However, there were higher rates of blood transfusions in patients 
with a noncompliant diagnosis. 
 
Logistic Regression Analysis Evaluating Factors Associated With A Diagnosis Of Noncompliance 
After performing multivariable adjusted logistic regression analysis, several factors were 
identified as being associated with a diagnosis of noncompliance (Table 2). Males were 29% more 
likely than females to be diagnosed with noncompliance and post-high school aged patients were 
45% more likely to receive a diagnosis of compliance compared with those in HS. Compared to 
non-Hispanic whites, blacks were 2.26 times (95% CI 1.83-2.77) more likely to receive a diagnosis 
of noncompliance. Both ES and MS patients were significantly less likely than HS patients to have 
received a diagnosis of noncompliance. Patients residing in suburban and rural settings were less 
likely to receive a diagnosis of noncompliance than those in urban settings. In evaluating the 
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relationship between income quartile and receiving a diagnosis of noncompliance, individuals in 
the lowest quartile (59%) had a higher likelihood of receiving the diagnosis compared to the 
highest income quartile. Patients with government health insurance were 2.34 times more likely 
(95% CI 1.90-2.88) to receive a diagnosis of noncompliance than those with private health 
insurance.  
 
Logistic Regression Evaluating The Association Between Comorbidities, Complications, And 
Interventions With A Diagnosis Of Noncompliance 
After multivariable adjusted logistic regression analysis, patients with a diagnosis of 
noncompliance had  a significantly increased odds of being diagnosed with anxiety (59%), anemia 
(61%), depression (92%), and nutritional deficiencies (65%), but had a decreased odds of intestinal 
obstruction (40%), peritoneal and intestinal abscesses (41%), and having an ostomy (54%) than 
children and young adults without the diagnosis of noncompliance. (Table 4). 
 Those with a noncompliant diagnosis were significantly less likely to have undergone a 
major surgical procedure or a large bowel resection but had a higher odds of receiving a blood 
transfusion. Patients with a noncompliant diagnosis were 29% lower odds to undergo a 




Chapter IV: Discussion 
To the best of our knowledge, this is the first study to describe and compare  the demographic 
characteristics of hospitalized pediatric patients in the United States with CD who received, as 
compared with those who did not receive, a diagnosis of noncompliance and to examine the 
associated comorbidities, disease-related complications, and interventions associated with this 
diagnosis. We found that there was an increased risk of comorbidities, complications and 
subsequent interventions associated with the diagnosis of noncompliance in hospitalized children 
and young adults with CD. 
 
Patient Characteristics Associated With A Diagnosis Of Noncompliance 
This study demonstrated that males were 29% more likely to be diagnosed with noncompliance 
than females (Table 2). This contrasts with one recent pediatric IBD study in which females were 
more non-adherent with medication than males [21]. Pediatric transplantation, another chronic 
disease state with a strong emphasis on medication compliance, has shown mixed results with 
several studies suggesting girls[27, 28] had more noncompliance while others failed to  find any  
differences in compliance between boys and girls[29, 30]. Similarly, studies in adults with  IBD 
have shown mixed results regarding gender differences[31, 32]. Additional longitudinal research 
will need to determine whether there are gender differences in noncompliance/nonadherence 
among  the population of  patients with pediatric IBD.  
Studies in adults with IBD  have shown that African-Americans have both lower 
compliance[33] and adherence[34] than non-Hispanic whites. In the present study, black children 
with CD were significantly more likely to receive a diagnosis of noncompliance than non-Hispanic 
whites. This finding is consistent with the results of the current literature among children and 
24 
young adults with other chronic diseases that have shown non-whites to be significantly more 
likely  to be noncompliant/nonadherent than whites[29, 35, 36]. The reasons for these differences 
are unclear, but possible explanations include differences in socioeconomic status, access to 
medications or healthcare providers, health literacy, family structure, or an implicit bias in the use 
of the diagnosis itself. Some of these factors have been studied with tailored interventions showing 
improvements in compliance[35, 37], but few have addressed the possibility of implicit bias. 
Implicit bias refers to attitudes and ideas that are outside of one’s awareness, cannot be recalled, 
and can be considered “unconscious.” The prejudice they impart may subtly alter treatment 
decisions[38]. Implicit bias has been demonstrated in the management of common pediatric 
disease states[39], and its impact in the present study cannot be excluded. 
 Older patients with CD had a significantly higher likelihood of being diagnosed with 
noncompliance as compared to those in HS whereas children in ES and MS were significantly less 
likely to receive this diagnosis. We believe that this is due to the increased role of parents in 
managing medical therapy in the younger age groups and the reluctance of health care providers 
to assign a diagnosis of noncompliance to a younger child when the challenges of care might 
involve the parents or caregivers more than the child themselves. Our findings that older 
adolescents were more likely to be diagnosed as noncompliant is consistent with the existing 
literature indicating a significant decrease in adherence with CD medications with increasing 
age[20]. 
 
Comorbidities Associated with Crohn’s Disease and Noncompliance 
Pediatric patients with IBD who are nonadherent to prescribed medical regimens have been 
demonstrated to achieve lower rates of symptom remission and have more hospitalizations than 
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patients who are adherent [21]. The increased likelihood of being diagnosed with both anemia and 
non-compliance in the present study was an interesting finding. Potential explanations include 
symptom escalation (and/or persistence), inadequate medical therapy or other potential 
comorbidities. However, due to the limitations of the KID, we cannot accurately assess all factors 
potentially associated with anemia. Additionally, we found blood transfusions were given more 
frequently to patients with a noncompliance diagnosis, which was expected given their higher rates 
of anemia. It is possible that the higher likelihood of having depression and anxiety in the 
noncompliant group reflects symptomatic CD. This finding would be consistent  with the existing 
literature which indicates that children with symptomatic CD have more severe depressive 
symptoms and a higher incidence of depressive mood diagnoses than children with CD not 
experiencing active symptoms[40].  
 
Complications Associated with Crohn’s Disease and Noncompliance 
We hypothesized that patients with a diagnosis of noncompliance would have a higher prevalence 
of disease complications due to the failure of the medications to achieve remission of symptoms, 
[20]. Surprisingly, we found lower rates of intestinal obstruction and peritoneal or intestinal 
abscesses in the noncompliant group. One hypothesis regarding the association between 
obstruction and anti-TNF agents (a mainstay of CD treatment) suggests that in stricturing-type CD 
anti-TNF agents, such as infliximab, cause rapid luminal healing resulting in fibrosis and scarring 
of the bowel wall with subsequent stenosis or obstruction. An early case series[41] raised this 
concern, but a study analyzing two long-term observational trials found that, after multivariable 
analysis, infliximab was not associated with intestinal stricture or obstruction[42]. An alternative 
explanation is that children might preferentially be started on infliximab by providers who have 
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concerns about their compliance.  The opportunity to directly observe the intravenous infusion of 
infliximab as an outpatient mitigates the risk of patients becoming noncompliant with oral 
medications. A limitation of the KID prevents evaluating medications taken by the patients, and 
so we cannot assert that the reason for lower rates of intestinal obstruction seen in the noncompliant 
group was from not taking anti-TNF agents but raises the opportunity for further study. 
 
Interventions Associated With Crohn’s Disease And A Diagnosis Of Noncompliance 
Patients with a diagnosis of noncompliance were less likely to undergo colonoscopy, a major 
surgical procedure, and large bowel resection than those without the diagnosis. Generally, in CD, 
surgery is reserved for the management of complications or failures of medical theory. It is 
surprising that noncompliant patients, who are more symptomatic, would undergo less critical 
interventions for which we offer two possible explanations. First, it is possible there is a reluctance 
on the part of providers to provide endoscopic or surgical intervention in a patient who is deemed 
noncompliant whether that be due to perceived higher risks associated with the intervention or due 
to the patient having more severe disease. Additionally, patients who carry a diagnosis of 
noncompliance may do so because of the refusal of medical therapy, and, by extension, they may 
be more likely to refuse endoscopic or surgical intervention. The lower rates of endoscopic or 
surgical intervention may be directly related to the diagnosis of noncompliance within that 
hospitalization.  
 
Future Areas of Research 
Further research in the area of treatment noncompliance within the pediatric IBD community is 
necessary to develop a universal definition and understanding of what entails one being 
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noncompliant with treatment. This will allow clinicians and researchers a universal definition from 
which to study clinical outcomes and ways to improve the care of children and young adults. Once 
a universal definition has been created, interventions and educational initiatives could be 
developed to reduce the rates of treatment noncompliance in this population. 
 
Study Strengths and Limitations  
The most significant advantage of this study is the utilization of the KID. It is the single largest 
national all-payer administrative dataset of children < 20 years of age within the United States. 
With over 3,500 participating hospitals, the KID is significantly larger than alternative data sources 
such as the Pediatric Health Information System (PHIS, ~ 45 participating hospitals) and the 
American College of Surgeons National Surgical Quality Improvement Program Pediatric (ACS 
NSQIP Peds, ~ 44 participating hospitals). The large size of the dataset allows for the study of 
disease states which would be challenging to study at a single institution.  
There are several limitations to this study – the reliance on ICD-9 codes, absence of 
disease-specific variables, the impact of missing data, and the lack of a longitudinal design. 
Diagnoses and procedures of interest were determined using ICD-9 codes. It cannot be determined 
whether the comorbidities or complications were present on admission or not. Additionally, one 
cannot be sure how thoroughly these diagnoses were captured, and any observed change may be 
more reflective of increased documentation and awareness as opposed to changes in practice or 
management. We did observe a slight  increase in the percentage of cases with a diagnosis of 
compliance annually from 2006 to 2012 but cannot conclude if that is due to generally increased 
noncompliance among pediatric CD patients or if greater awareness of billing and coding resulted 
in this finding. There are several disease-specific variables which would further our understanding 
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of these findings but are not available in the dataset. For example, there are limitations to the ICD-
9 codes regarding the location of CD within the intestinal tract, and no variables indicating the 
severity of the disease. Furthermore, the disease duration for each patient would be a helpful metric 
in understanding a diagnosis of noncompliance in perspective of the patient’s overall disease 
course. However, there are no national CD specific databases spanning multiple years to the best 
of our knowledge. The presence of missing data represents a significant challenge and is 
predominately due to individual state’s decision not to include variables, particularly race 
However, the prevalence of noncompliance within the excluded cases was similar to the included 
cases (3.6% vs. 2.9-4.8%). Finally, the KID is not a patient-level database nor longitudinal in 
design, and it is not possible to determine whether patients had one or multiple hospitalizations in 





Chapter V: Conclusions 
A diagnosis of treatment noncompliance has a substantial impact on the care of hospitalized 
pediatric patients with CD. We observed significant variation in the application of this diagnosis 
with a predominance of blacks, urban residents, low income, and government health insured 
patients being labelled with this term. Additionally, there appears to be a difference in the inpatient 
management and interventions for those with a diagnosis of noncompliance compared to those 
without. The long and short-term adverse sequelae of noncompliance with medical therapy pose 
significant health concerns including the risk of escalation of comorbidities and disease-related 
complications. This highlights the importance of interventions to improve compliance and 
adherence in this population. Uniform guidelines should be developed to better define 
noncompliance and nonadherence in the pediatric IBD community. To improve care and eliminate 
bias, an understanding of the risks associated with these diagnoses will provide the necessary 
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Table 1: Patient Characteristics According to a Diagnosis of Noncompliance 
 Noncompliant Compliant  
 (n = 1,028) (n = 27,309) p-value 
 n (%) n(%)  
Age, mean (years, ± Std. Dev) 17.6 (3.0) 15.8 (4.6) <0.01 
School Age Groupings:    
Elementary (0-10 years) 19 (1.8) 2,543 (9.3) <0.01 
Middle School (11-13 years) 51 (5.0) 3,769 (13.8) <0.01 
High School (14-18 years) 492 (47.9) 12,827 (47.0) 0.65 
Post-High School (19+ years) 466 (45.3) 8,171 (29.9) <0.01 
Male 570 (55.4) 13,915 (51.0) 0.04 
Race    
Non-Hispanic White 524 (51.0) 19,684 (72.1) <0.01 
Black 381 (37.0) 4,019 (14.7) <0.01 
Hispanic 81 (7.9) 2,117 (7.8) 0.90 
Asian or Pacific Islander NR 333 (1.2) 0.02 
Native American NR 83 (0.3) 0.69 
Other 35 (3.4) 1,074 (3.9) 0.56 
Region    
Northeast 298 (29.0) 7,888 (28.9) 0.95 
Midwest 175 (17.0) 5,166 (18.9) 0.33 
South 399 (35.6) 9,687 (35.5) 0.14 
West 144 (14.1) 4,148 (15.2) 0.46 
Elective Admission 103 (10.1) 4,954 (18.2) <0.01 
Length of Stay, mean (days, ± Std. Dev) 5.5 (7.0) 5.5 (8.2) 0.93 
Median Income Quartile by Zip Code    
1st  349 (33.9) 5,763 (21.1) <0.01 
2nd  217 (21.1) 5,845 (21.4) 0.83 
3rd  249 (24.2) 6,661 (24.4) 0.92 
4th  214 (20.8) 9,040 (33.1) <0.01 
Setting    
Urban 713 (69.4) 16,363 (59.9) <0.01 
Suburban 219 (21.3) 7,092 (26.0) 0.01 
Rural 79 (7.7) 3,417 (12.5) <0.01 
Payer    
Private 402 (39.1) 17,972 (65.8) <0.01 
Government 476 (46.3) 6,867 (25.1) <0.01 
Other 150 (14.6) 2,471 (9.1) <0.01 
Percent of cases by year    
2006 231 (3.3) 6,744 (96.7) 0.28 
2009 354 (3.6) 9,576 (96.4) 0.77 
2012 443 (3.9) 10,990 (96.1) 0.21 
NR = Not Reported in conjunction with data use agreement 
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Gender   
Male 1.29 (1.08, 1.54) 
Female Reference  
Race   
Non-Hispanic White Reference  
Black 2.26 (1.83, 2.77) 
Hispanic 0.94 (0.63, 1.40) 
Asian or Pacific Islander 0.26 (0.06, 1.05) 
Native American 1.60 (0.38, 6.81) 
Other 1.02 (0.61, 1.71) 
School Age Groups   
Elementary (0-10 years) 0.19 (0.11, 0.25) 
Middle School (11-13 years) 0.37 (0.24, 0.55) 
High School (14-18 years) Reference  
Post-High School (19+ years) 1.45 (1.22, 1.73) 
Setting   
Urban Reference  
Suburban 0.71 (0.57, 0.89) 
Rural 0.49 (0.35, 0.68) 
Median Income Quartile by Zip Code   
1st 1.59 (1.22, 2.08) 
2nd 1.29 (0.98, 1.69) 
3rd 1.45 (1.12, 1.89) 
4th Reference  
Payer   
Private Reference  
Government 2.34 (1.90, 2.88) 
Other 1.97 (1.53, 2.53) 
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Table 3: Comorbidities, Complications And Interventions Associated with A Diagnosis Of 
Noncompliance 
 
 Noncompliant Compliant 
 N (%) N (%) 
Associated Comorbidities   
Anxiety 55 (5.4) 1,031 (3.8) 
Anemia 380 (36.9) 6,553 (24.0) 
Depression 84 (8.2) 1,109 (4.1) 
Nutritional Deficiency 142 (13.8) 2,207 (8.1) 
   
Disease-Related Complications   
Intestinal Obstruction 41 (4.0) 1,715 (6.3) 
Perianal Disease 59 (5.7) 1,191 (4.4) 
Peritonitis NR (0.4) 325 (1.2) 
Peritoneal/Intestinal Abscess 37 (3.6) 1,579 (5.8) 
Ostomy 20 (2.0) 1,136 (4.2) 
   
Interventions   
Upper gastrointestinal endoscopy 130 (12.7) 4,652 (17.0) 
Colonoscopy 156 (15.2) 5,764 (21.1) 
Vascular Catheterization 126 (12.2) 3,394 (12.4) 
Blood Transfusion 105 (10.2) 1,602 (5.9) 
Enteral/Parenteral Nutrition Use 114 (11.1) 3,115 (11.4) 
Major Surgical Procedure 98 (9.6) 5,647 (20.7) 
Small Bowel Resection 20 (1.9) 748 (2.7) 
Large Bowel Resection 44 (4.3) 2,474 (9.16) 
NR = Not Reported in conjunction with data use agreement  
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Table 4: Logistic Regression Analysis  Of Comorbidities, Complications, And Interventions Associated With A Diagnosis Of 
Noncompliance 
 
 Crude Odds Ratio 95% Confidence Interval Adjusted Odds Ratio* 95% Confidence Interval 
Associated Comorbidities     
Anxiety 1.45 (1.05, 2.01) 1.59 (1.12, 2.24) 
Anemia 1.85 (1.57, 2.19) 1.61 (1.36, 1.92) 
Depression 2.11 (1.55, 2.86) 1.92 (1.39, 2.66) 
Nutritional Deficiency 1.82 (1.46, 2.28) 1.65 (1.31, 2.08) 
     
Disease-Related Complications     
Intestinal Obstruction 0.62 (0.40, 0.94) 0.60 (0.39, 0.94) 
Perianal Disease 1.34 (0.95, 1.89) 1.30 (0.91, 1.86) 
Peritonitis 0.35 (0.11, 1.11) 0.36 (0.11, 1.15) 
Peritoneal/Intestinal Abscess 0.61 (0.40, 0.92) 0.59 (0.38, 0.90) 
Ostomy 0.47 (0.28, 0.79) 0.46 (0.26, 0.80) 
     
Interventions     
Upper gastrointestinal endoscopy 0.71 (0.54, 0.84) 0.82 (0.63, 1.06) 
Colonoscopy 0.67 (0.54, 0.84) 0.71 (0.56, 0.90) 
Vascular Catheterization 0.98 (0.78, 1.24) 1.04 (0.82, 1.33) 
Blood Transfusion 1.82 (1.41, 2.35) 1.57 (1.19, 2.06) 
Enteral/Parenteral Nutrition Use 0.97 (0.73, 1.25) 1.14 (0.87, 1.47) 
Major OR Procedure 0.41 (0.31, 0.53) 0.40 (0.31, 0.53) 
Small Bowel Resection 0.69 (0.39, 1.21) 0.76 (0.43, 1.34) 
Large Bowel Resection 0.45 (0.32, 0.65) 0.44 (0.31, 0.64) 











Figure 2 – Map of U.S. States by U.S. Census Bureau Regions 
 
 
 
